Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box Social Bookmarking
 Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter
What's this?
box PubMed
Articles in PubMed by Author:
 arrow  Hummel, M.
space
 arrow  Ziegler, A.-G
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Brief Communication: Early Appearance of Islet Autoantibodies Predicts Childhood Type 1 Diabetes in Offspring of Diabetic Parents

right arrow Michael Hummel, MD; Ezio Bonifacio, PhD; Sandra Schmid, PhD; Markus Walter, MD; Annette Knopff; and Anette-G Ziegler, MD

1 June 2004 | Volume 140 Issue 11 | Pages 882-886

Background: The development of type 1 diabetes mellitus is preceded by autoimmunity against islet ß cells.

Objective: To determine the risk for islet autoimmunity and childhood diabetes in offspring of affected parents.

Design: Prospective cohort study.

Setting: German BABYDIAB study.

Participants: 1610 offspring of parents with type 1 diabetes.

Measurements: Autoantibodies to islet autoantigens were measured at 9 months, 2 years, 5 years, and 8 years of age.

Results: By 5 years of age, the frequency of islet autoantibodies was 5.9% (95% CI, 4.6% to 7.2%), the frequency of multiple islet autoantibodies was 3.5% (CI, 2.5% to 4.5%), and the frequency of diabetes was 1.5% (CI, 0.9% to 2.1%). The risk for diabetes was highest in offspring with multiple autoantibodies (40% within 5 years vs. 3% in offspring with single autoantibodies; P = 0.005). Progression to multiple islet autoantibodies was fastest in children who were autoantibody positive by age 2 years (P < 0.001), and progression to diabetes was inversely related to the age of positivity for multiple autoantibodies (P = 0.02).

Limitations: The findings are limited to childhood diabetes in affected families.

Conclusions: Childhood autoimmune diabetes is associated with autoimmunity that starts before 2 years of age.


Editors' Notes
space

Context

  • The BABYDIAB study is a prospective study of the development of autoimmunity to islet cells and diabetes among offspring of parents with type 1 diabetes.

Contribution

  • Children with multiple autoantibodies were at the greatest risk for developing diabetes, especially if they developed autoantibodies by age 2 years. Of children who developed multiple autoantibodies before age 9 months, 50% developed diabetes within 2 years compared with only 7% of those who developed multiple autoantibodies at age 5 years.

Implications

  • Periodic testing for autoantibodies can help assess the risk for diabetes in offspring of parents with type 1 diabetes.

–The Editors

 

Author and Article Information
space

From Diabetes Research Institute and Academic Hospital Schwabing, Munich, Germany, and Istituto Scientifico San Raffaele, Milan, Italy.

Acknowledgments: The authors thank Andrea Baumgarten, Ulrike Mollenhauer, Doris Huber, Kerstin Koczwara, Katharina Warncke, and Mike Schenker for expert technical assistance. They also thank all pediatricians and family doctors in Germany for participation in the BABYDIAB study.

Grant Support: By grants from the Juvenile Diabetes Research Foundation (JDRF #1-2003-646), the Stiftung ‘Das Zuckerkranke Kind’, the Bundesministerium für Forschung und Technologie (BMFT 01KD89030), and the Deutsche Diabetesgesellschaft (Dr. Buding-Stiftung).

Potential Financial Conflicts of Interest: None disclosed.

Requests for Single Reprints: Anette-G. Ziegler, MD, Institut für Diabetesforschung, Kölner Platz 1, D-80804 München, Germany; e-mail, anziegler{at}lrz.uni-muenchen.de.

Current Author Addresses: Dr. Hummel: Academic Hospital Schwabing, Kölner Platz 1, D-80804 München, Germany.

Dr. Bonifacio: Immunology of Diabetes, San Raffaele Scientific Institute, Via Olgettina 60, I-20132 Milan, Italy.

Drs. Schmid, Walter, and Ziegler, and Ms. Knopff: Diabetes Research Institute, Kölner Platz 1, D-80804 München, Germany.

Author Contributions: Conception and design: M. Hummel, A. Ziegler.

Analysis and interpretation of the data: M. Hummel, E. Bonifacio, S. Schmid, A. Ziegler.

Drafting of the article: M. Hummel, E. Bonifacio, A. Ziegler.

Critical revision of the article for important intellectual content: E. Bonifacio, S. Schmid, M. Walter, A. Ziegler.

Final approval of the article: M. Hummel, E. Bonifacio, S. Schmid, M. Walter, A. Knopff, A. Ziegler.

Provision of the study materials or patients: M. Hummel, M. Walter, A. Ziegler.

Statistical expertise: E. Bonifacio.

Obtaining of funding: A. Ziegler.

Administrative, technical, or logistic support: E. Bonifacio, S. Schmid, M. Walter, A. Knopff, A. Ziegler.

Collection and assembly of the data: M. Hummel, S. Schmid, M. Walter, A. Knopff, A. Ziegler.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in Annals:

Summaries for Patients
Development of Islet Cell Autoantibodies and Type 1 Diabetes
Annals 2004 140: I-64. [Full Text]  



This article has been cited by other articles:


Home page
DiabetesHome page
A. Mayr, M. Schlosser, N. Grober, H. Kenk, A. G. Ziegler, E. Bonifacio, and P. Achenbach
GAD Autoantibody Affinity and Epitope Specificity Identify Distinct Immunization Profiles in Children at Risk for Type 1 Diabetes
Diabetes, June 1, 2007; 56(6): 1527 - 1533.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler
Natural History of Type 1 Diabetes
Diabetes, December 1, 2005; 54(suppl_2): S25 - S31.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Huppmann, A. Baumgarten, A.-G. Ziegler, and E. Bonifacio
Neonatal Bacille Calmette-Guerin Vaccination and Type 1 Diabetes
Diabetes Care, May 1, 2005; 28(5): 1204 - 1206.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., September 1, 2004; 9(5): e5 - e5.
[Full Text] [PDF]


Home page
JWatch PediatricsHome page
Diabetes in the Parent May Predict Type 1 Diabetes in the Child
Journal Watch Pediatrics and Adolescent Medicine, July 12, 2004; 2004(712): 5 - 5.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2004 by the American College of Physicians.